| ٹائم فریم | پیش گوئی کی قیمت | ماضی | تاریخی | بصیرت |
|---|---|---|---|---|
| کل | $14.44 ▲ +1.15% | کل | $14.21 ▼ -0.48% | Tomorrow's Viridian Therapeutics Inc. Common Stock (VRDN) setup is anchored to $14.28 and targets $14.44 (+1.15%). The near-term read is upside; watch $14.71 / $13.85 because daily realized volatility is about 5.93%. |
Tomorrow's Viridian Therapeutics Inc. Common Stock (VRDN) setup is anchored to $14.28 and targets $14.44 (+1.15%). The near-term read is upside; watch $14.71 / $13.85 because daily realized volatility is about 5.93%. | ||||
| ہفتے | $14.79 ▲ +3.58% | آخری ہفتے | $14.07 ▼ -1.50% | The 7-day Viridian Therapeutics Inc. Common Stock model moves from $14.07 to $14.79 (+3.58%). It gives upside momentum context for this stock, so breaks around $14.71 / $13.85 matter more than a single tick. |
The 7-day Viridian Therapeutics Inc. Common Stock model moves from $14.07 to $14.79 (+3.58%). It gives upside momentum context for this stock, so breaks around $14.71 / $13.85 matter more than a single tick. | ||||
| مہینہ | $15.37 ▲ +7.61% | پچھلے مہینے | $13.82 ▼ -3.20% | The 1-month Viridian Therapeutics Inc. Common Stock target is $15.37 (+7.61%), compared with the live reference near $14.28. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Viridian Therapeutics Inc. Common Stock target is $15.37 (+7.61%), compared with the live reference near $14.28. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| سال | $16.23 ▲ +13.67% | پچھلے سال | $13.46 ▼ -5.74% | The 1-year Viridian Therapeutics Inc. Common Stock scenario points to $16.23 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Viridian Therapeutics Inc. Common Stock scenario points to $16.23 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 سال | $18.26 ▲ +27.86% | 5 سال پہلے | $12.61 ▼ -11.70% | The 5-year Viridian Therapeutics Inc. Common Stock view is $18.26 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Viridian Therapeutics Inc. Common Stock view is $18.26 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| اشارے | قیمت | اشارہ |
|---|---|---|
| Price | $14.28 | Mid |
| Daily Change | -2.73% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 63% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $14.28 | Daily Change | -2.73% |
| Market Cap | $1.47B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.